For several decades there has been an accumulation of data from epidemiological studies, basic science research and studies related to patient groups with altered levels of GH/IGF-1 which has suggested that the GH/IGF-1 system may be associated with either tumourigenesis or more aggressive behaviour in cancers (Holly et al., 1999). Here, IGF1 is linked to cancer.